Literature DB >> 30467620

Stress as an immunomodulator: liver X receptors maybe the answer.

Issam Nessaibia1,2, Allan Fouache3, Jean-Marc A Lobaccaro3, Abdelkrim Tahraoui4, Amalia Trousson3, Maâmar Souidi5.   

Abstract

Stress is a reflex response, both psychological and physiological, of the body to a difficult situation that requires adaptation. Stress is at the intersection of the objective event and the subjective event. The physiological mechanisms involved in chronic stress are numerous and can contribute to a wide variety of disorders, in all systems including the immune system. Stress modifies the Th1/Th2 balance via the HPA axis and a set of immune mediators. This will make the body more vulnerable to external infections in a scientific way while others claim the opposite, stress could be considered immune stimulatory. The development of synthetic LXR ligands such as T0901317 and GW3965 as well as an understanding of the direct involvement of these receptors in the regulation of proopiomelanocortin (POMC) gene expression and indirectly by producing a variety of cytokines in a stressor response, will open in the near future new therapeutic methods against the undesirable effects of stress on the behavior of the immune system.

Entities:  

Keywords:  Hypothalamus pituitary adrenal (HPA); Infectious diseases; Liver X receptors; Stress; Th1/Th2 balance

Mesh:

Substances:

Year:  2018        PMID: 30467620     DOI: 10.1007/s10787-018-0546-1

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  102 in total

1.  Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease.

Authors: 
Journal:  Trends Endocrinol Metab       Date:  1999-11       Impact factor: 12.015

Review 2.  Interleukin 1 in the brain: biology, pathology and therapeutic target.

Authors:  N J Rothwell; G N Luheshi
Journal:  Trends Neurosci       Date:  2000-12       Impact factor: 13.837

3.  Psychophysiological stress responses, muscle tension, and neck and shoulder pain among supermarket cashiers.

Authors:  U Lundberg; I E Dohns; B Melin; L Sandsjö; G Palmerud; R Kadefors; M Ekström; D Parr
Journal:  J Occup Health Psychol       Date:  1999-07

Review 4.  Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis.

Authors:  John J Haddad; Nayef E Saadé; Bared Safieh-Garabedian
Journal:  J Neuroimmunol       Date:  2002-12       Impact factor: 3.478

5.  Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination.

Authors:  K Vedhara; N K Cox; G K Wilcock; P Perks; M Hunt; S Anderson; S L Lightman; N M Shanks
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

6.  Symptoms of stress and depression as correlates of sleep in primary insomnia.

Authors:  M Hall; D J Buysse; P D Nowell; E A Nofzinger; P Houck; C F Reynolds; D J Kupfer
Journal:  Psychosom Med       Date:  2000 Mar-Apr       Impact factor: 4.312

7.  Time-series analysis of the relationship between dizziness and stress.

Authors:  G Andersson; L Yardley
Journal:  Scand J Psychol       Date:  2000-03

Review 8.  Neuroendocrine aspects of the response to stress.

Authors:  Diane B Miller; James P O'Callaghan
Journal:  Metabolism       Date:  2002-06       Impact factor: 8.694

9.  A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis.

Authors:  A Chawla; W A Boisvert; C H Lee; B A Laffitte; Y Barak; S B Joseph; D Liao; L Nagy; P A Edwards; L K Curtiss; R M Evans; P Tontonoz
Journal:  Mol Cell       Date:  2001-01       Impact factor: 17.970

10.  Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production.

Authors:  Ashley J Fowler; Mary Y Sheu; Matthias Schmuth; Jack Kao; Joachim W Fluhr; Linda Rhein; Jon L Collins; Timothy M Willson; David J Mangelsdorf; Peter M Elias; Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2003-02       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.